Todd Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Todd Asset Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-716,331	Closed	-$57.1M	–	222
2022 Q2	$57.1M	Buy	716,331 +158,636	+28%	+$15M	1.47%	7
2022 Q1	$58.6M	Buy	557,695 +39,969	+8%	+$3.9M	1.29%	10
2021 Q4	$55.8M	Sell	517,726 -49,145	-9%	-$5.36M	1.2%	12
2021 Q3	$62.1M	Buy	566,871 +138,177	+32%	+$14.3M	1.42%	7
2021 Q2	$40.1M	Buy	428,694 +386,694	+921%	+$35.6M	0.91%	27
2021 Q1	$3.87M	Buy	42,000 +12,200	+41%	+$1.03M	0.09%	148
2020 Q4	$2.18M	Buy	+29,800	New	+$2.22M	0.06%	163

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Todd Asset Management's HZNP Position: Q3 2022 in Review

Todd Asset Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q3 2022, closing a stake of 716,331 shares — an estimated $57.1M sold.

Todd Asset Management first reported a position in HZNP in Q4 2020 and held it in 7 quarters. The position peaked at $62.1M in Q3 2021. 529 funds tracked by Wall St. Rank hold HZNP as of Q3 2022.

Todd Asset Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q3 2022 after selling out during the quarter.
Todd Asset Management sold 716,331 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2022, an estimated $57.1M.
Todd Asset Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2020 and held it in 7 quarters.
Todd Asset Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $62.1M in Q3 2021.
529 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2022.

Based on Todd Asset Management's 13F filing for Q3 2022, filed 8 Nov 2022.